Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
startups
antisense oligonucleotide
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
clinical trials
columbia university
dacogen
david goldstein
deals
decitabine
depression
dna
epi4k
epigenetics
epilepsy
epizyme
essential tremor
farydak
flagship pioneering
fulcrum therapeutics
insulated genomic domains
investing
kaleido biosciences
kiran reddy
mahesh karande
major depressive disorder
marcio souza
What
aims
2
×
drugs
medicines
new
research
approach
backed
based
biotech
called
cause
ceo
debuts
developing
epigenetic
epigenetics
epilepsy
field
flagship’s
genes
genetic
links
marcio
morning
mutations
neuro
omega
praxis
precision
souza
startup
step
stop
therapeutics
touting
turn
Language
unset
Current search:
aims
×
boston
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
